Compare Vertex Pharmaceuticals Incorporated (VRTX) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs Wells Fargo & Co — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.09 (market cap $121.95B), while Wells Fargo & Co trades at $87.9 (market cap $261.45B). The key difference: Wells Fargo & Co is far larger — about 2.1× Vertex Pharmaceuticals Incorporated's market cap, and Wells Fargo & Co pays a 2.09% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| VRTX | WFC | |
|---|---|---|
Market Cap | $121.95B | $261.45B |
Sector | Health | Financials |
52-Week High | $529.59 | $96.40 |
52-Week Low | $366.54 | $73.42 |
Enterprise Value | $116.69B | — |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
